Improving cardiac function and shrinking myocardial infarction size, alleviating myocardial injury and fibrosis by hampering IL-1β, IL-6, and TNF-α mRNA levels, CD68 and COX-2 protein expressions, and TGF-β/Smad signaling pathway activation. The gene discussed is PTGS2; the disease is myocardial infarction.